NTLA logo

Intellia Therapeutics, Inc. (NTLA) Operating Profit

Annual Operating Profit:

-$534.26M-$18.97M(-3.68%)
December 31, 2024

Summary

  • As of today, NTLA annual operating income is -$534.26 million, with the most recent change of -$18.97 million (-3.68%) on December 31, 2024.
  • During the last 3 years, NTLA annual operating profit has fallen by -$266.41 million (-99.46%).
  • NTLA annual operating profit is now -15234.76% below its all-time high of -$3.48 million, reached on December 31, 2014.

Performance

NTLA Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAincome statement metrics

Quarterly Operating Profit:

-$111.48M-$1.48M(-1.35%)
September 30, 2025

Summary

  • As of today, NTLA quarterly operating income is -$111.48 million, with the most recent change of -$1.48 million (-1.35%) on September 30, 2025.
  • Over the past year, NTLA quarterly operating profit has increased by +$33.29 million (+23.00%).
  • NTLA quarterly operating profit is now -9228.62% below its all-time high of -$1.20 million, reached on March 31, 2015.

Performance

NTLA Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAincome statement metrics

TTM Operating Profit:

-$472.23M+$33.29M(+6.59%)
September 30, 2025

Summary

  • As of today, NTLA TTM operating income is -$472.23 million, with the most recent change of +$33.29 million (+6.59%) on September 30, 2025.
  • Over the past year, NTLA TTM operating profit has increased by +$65.48 million (+12.18%).
  • NTLA TTM operating profit is now -39416.90% below its all-time high of -$1.20 million, reached on March 31, 2015.

Performance

NTLA TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

NTLA Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-3.7%+23.0%+12.2%
3Y3 Years-99.5%-5.6%-10.2%
5Y5 Years-402.3%-296.7%-281.0%

NTLA Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-99.5%at low-5.6%+23.0%-10.9%+12.2%
5Y5-Year-402.3%at low-296.7%+23.0%-281.0%+12.2%
All-TimeAll-Time>-9999.0%at low-9228.6%+23.0%>-9999.0%+12.2%

NTLA Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$111.48M(-1.3%)
-$472.23M(+6.6%)
Jun 2025
-
-$110.00M(+3.8%)
-$505.52M(+5.4%)
Mar 2025
-
-$114.31M(+16.2%)
-$534.57M(-0.1%)
Dec 2024
-$534.26M(-3.7%)
-$136.45M(+5.7%)
-$534.26M(+0.6%)
Sep 2024
-
-$144.77M(-4.1%)
-$537.71M(-2.6%)
Jun 2024
-
-$139.04M(-22.0%)
-$524.04M(-1.3%)
Mar 2024
-
-$114.00M(+18.5%)
-$517.34M(-0.4%)
Dec 2023
-$515.29M(-12.5%)
-$139.89M(-6.7%)
-$515.29M(-6.1%)
Sep 2023
-
-$131.11M(+0.9%)
-$485.49M(-5.6%)
Jun 2023
-
-$132.33M(-18.2%)
-$459.91M(-8.0%)
Mar 2023
-
-$111.96M(-1.7%)
-$425.88M(+7.0%)
Dec 2022
-$458.16M(-71.1%)
-$110.09M(-4.3%)
-$458.16M(-6.9%)
Sep 2022
-
-$105.53M(-7.4%)
-$428.49M(-8.5%)
Jun 2022
-
-$98.30M(+31.9%)
-$394.95M(-8.0%)
Mar 2022
-
-$144.25M(-79.4%)
-$365.67M(-36.5%)
Dec 2021
-$267.85M(-96.1%)
-$80.42M(-11.7%)
-$267.85M(-16.5%)
Sep 2021
-
-$71.99M(-4.3%)
-$229.83M(-23.6%)
Jun 2021
-
-$69.02M(-48.7%)
-$185.94M(-24.0%)
Mar 2021
-
-$46.42M(-9.5%)
-$149.96M(-9.8%)
Dec 2020
-$136.58M
-$42.40M(-50.9%)
-$136.58M(-10.2%)
Sep 2020
-
-$28.10M(+14.9%)
-$123.95M(-2.3%)
Jun 2020
-
-$33.03M(+0.0%)
-$121.18M(-4.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$33.05M(-11.0%)
-$115.61M(-8.7%)
Dec 2019
-$106.37M(-17.1%)
-$29.77M(-17.5%)
-$106.37M(-9.3%)
Sep 2019
-
-$25.33M(+7.8%)
-$97.34M(-1.3%)
Jun 2019
-
-$27.46M(-15.3%)
-$96.11M(-4.2%)
Mar 2019
-
-$23.81M(-14.8%)
-$92.25M(-1.5%)
Dec 2018
-$90.87M(-30.6%)
-$20.75M(+13.9%)
-$90.87M(+4.2%)
Sep 2018
-
-$24.10M(-2.1%)
-$94.84M(-9.5%)
Jun 2018
-
-$23.59M(-5.2%)
-$86.61M(-9.6%)
Mar 2018
-
-$22.43M(+9.2%)
-$79.04M(-13.6%)
Dec 2017
-$69.56M(-116.3%)
-$24.71M(-55.7%)
-$69.56M(-25.0%)
Sep 2017
-
-$15.88M(+0.9%)
-$55.66M(-17.2%)
Jun 2017
-
-$16.02M(-23.7%)
-$47.48M(-23.6%)
Mar 2017
-
-$12.95M(-19.6%)
-$38.41M(-19.4%)
Dec 2016
-$32.16M(-139.8%)
-$10.82M(-40.6%)
-$32.16M(-19.9%)
Sep 2016
-
-$7.70M(-10.8%)
-$26.83M(-19.6%)
Jun 2016
-
-$6.95M(-3.8%)
-$22.43M(-18.6%)
Mar 2016
-
-$6.69M(-21.9%)
-$18.91M(-41.0%)
Dec 2015
-$13.41M(-284.9%)
-$5.49M(-66.3%)
-$13.41M(-69.3%)
Sep 2015
-
-$3.30M(+3.5%)
-$7.92M(-71.5%)
Jun 2015
-
-$3.42M(-186.4%)
-$4.62M(-286.4%)
Mar 2015
-
-$1.20M
-$1.20M
Dec 2014
-$3.48M
-
-

FAQ

  • What is Intellia Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Intellia Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Intellia Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. TTM operating profit year-on-year change?

What is Intellia Therapeutics, Inc. annual operating income?

The current annual operating profit of NTLA is -$534.26M

What is the all-time high annual operating profit for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high annual operating income is -$3.48M

What is Intellia Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, NTLA annual operating income has changed by -$18.97M (-3.68%)

What is Intellia Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of NTLA is -$111.48M

What is the all-time high quarterly operating profit for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high quarterly operating income is -$1.20M

What is Intellia Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, NTLA quarterly operating income has changed by +$33.29M (+23.00%)

What is Intellia Therapeutics, Inc. TTM operating income?

The current TTM operating profit of NTLA is -$472.23M

What is the all-time high TTM operating profit for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high TTM operating income is -$1.20M

What is Intellia Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, NTLA TTM operating income has changed by +$65.48M (+12.18%)
On this page